What's New

• 22 Oct 2020
  Antares Pharma to Report Third Quarter 2020 Finanical and Operating Results Read More

• 01 Oct 2020
  Antares Pharma Enters Exclusive License Agreement with Ferring Pharmaceuticals For Nocdurna® In U.S. Read More

• 08 Sep 2020
  Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Read More